Targeting human 8-oxoguanine glycosylase to mitochondria of oligodendrocytes protects against menadione-induced oxidative stress.
Within the central nervous system (CNS), there is a differential susceptibility among cell types to certain pathological conditions believed to involve oxidative stress. Oligodendrocytes are extremely sensitive to oxidative stress, which correlates with a decreased ability to repair damage in mitochondrial DNA (mtDNA), as we have shown previously. To determine whether there is a causal relationship, studies were carried out to correct the deficit in repair of the oxidative damage in mtDNA in cultured oligodendrocytes. A vector containing a mitochondrial transport sequence (MTS) upstream of the sequence for human 8-oxoguanine-DNA glycosylase (OGG) was transfected into the cells. The efficiency of transfection and the localization of recombinant protein were determined by fluorescence microscopy and by Western blot analysis. Subsequent mtDNA repair studies, employing 100 micro M menadione to produce reactive oxygen species, showed a significant enhancement in repair of oxidative lesions in mtDNA of MTS-OGG transfected oligodendrocytes compared with cells transfected with vector only. Experiments were also conducted to determine the effect of changing mtDNA repair capacity on menadione-induced apoptosis in oligodendrocytes. These experiments show that targeting the OGG repair enzyme to mitochondria reduces the release of cytochrome c from the intermitochondrial space and the activation of caspase 9 in oligodendrocytes after exposure to menadione. Therefore, targeting of DNA repair enzymes to mitochondria appears to be a viable approach for the protection of cells against some of the deleterious effects of oxidative stress.
Department of Cell Biology and Neuroscience, University of South Alabama, Mobile, Alabama 36688, USA.
Nadiya M
NM
Druzhyna
Scott B
SB
Hollensworth
Mark R
MR
Kelley
Glenn L
GL
Wilson
Susan P
SP
Ledoux
D000818:Animals; D000933:Antifibrinolytic Agents / Q000494:pharmacology; D017209:Apoptosis / Q000502:physiology; D002478:Cells, Cultured; D004249:DNA Damage / Q000502:physiology; D004260:DNA Repair / Q000502:physiology; D004272:DNA, Mitochondrial / Q000235:genetics / Q000378:metabolism; D043382:DNA-Formamidopyrimidine Glycosylase; D006801:Humans; D008928:Mitochondria / Q000201:enzymology*; D009699:N-Glycosyl Hydrolases / Q000235:genetics* / Q000378:metabolism*; D009836:Oligodendroglia / Q000166:cytology / Q000201:enzymology*; D018384:Oxidative Stress / Q000187:drug effects / Q000502:physiology*; D051381:Rats; D017382:Reactive Oxygen Species / Q000378:metabolism; D014162:Transfection / Q000379:methods; D024483:Vitamin K 3 / Q000494:pharmacology
D000933:Antifibrinolytic Agents; D004272:DNA, Mitochondrial; D017382:Reactive Oxygen Species; D024483:Vitamin K 3; D009699:N-Glycosyl Hydrolases; D043382:DNA-Formamidopyrimidine Glycosylase